✦ LIBER ✦

Late Relapses following High-Dose Autologous Stem Cell Transplantation (HD-ASCT) for Hodgkin’s Lymphoma (HL) in the ABVD Therapeutic Era

✍ Scribed by Sarah F. Keller; Jennifer L. Kelly; Elizabeth Sensenig; Jennifer Andreozzi; Jamie Oliva; Lynn Rich; Louis Constine; Michael Becker; Gordon Phillips; Jane Liesveld; Richard I. Fisher; Steven H. Bernstein; Jonathan W. Friedberg

Book ID: 116282744
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 399 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.08.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy and Autologous St

High dose chemotherapy and Autologous Stem Cell Transplantation (ASCT) in Hodgkin’s Disease (HD) with ≥2 reLapses—tata memorial hospital data

✍ P.S.R.K. Sastry; P. Narayanan; A. Bakshi; R. Bhagwat; G. Biswas; A. Khadwal; B.K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

145: ID/KLH active immunotherapy (FAVID®

145: ID/KLH active immunotherapy (FAVID®) following high dose therapy (HDT) and autologous stem cell transplantation (ASCT) for non-hodgkin’s lymphoma (NHL)

✍ P.P. Holman; M. deMagalhaes-Silverman; S. Corringham; J.E. Castro; E. Carrier; T 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Double High Dose Salvage Therapy With Do

Double High Dose Salvage Therapy With Dose-Intensified Cyclophosphamide, Etoposide, and Cisplatin (DICEP) Re-Induction Followed by High-Dose Melphalan (HDM) and Autologous Stem Cell Transplantation (ASCT) Consolidation for Relapsed/Refractory Hodgkin Lymphoma

✍ M. Shafey; Q. Duan; J.A. Russell; P. Duggan; A. Balogh; D.A. Stewart 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Autologous Stem Cell Transplantation for

Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome

✍ Nieto, Yago; Popat, Uday; Anderlini, Paolo; Valdez, Ben; Andersson, Borje; Liu, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 299 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy

✍ Arturo Molina; Amrita Y. Krishnan; Auayporn Nademanee; Rachel Zabner; Irena Snie 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Feasibility and Efficacy of High-Dose Me

Feasibility and Efficacy of High-Dose Melphalan, Cyclophosphamide, Etoposide, and Dexamethasone (LEED) Chemotherapy with or without Rituximab Followed by Autologous Stem Cell Transplantation for Aggressive and Relapsed Non-Hodgkin’s Lymphoma

✍ Li-na Han; Jin Zhou; Takayuki Hirose; Yosuke Imai; Takuro Ishiguro; Takaaki Chou 📂 Article 📅 2006 🏛 Carden Jennings Publishing 🌐 English ⚖ 137 KB